266 related articles for article (PubMed ID: 33510368)
1. Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum.
Liu L; Aron CZ; Grable CM; Robles A; Liu X; Liu Y; Fatheree NY; Rhoads JM; Alcorn JL
Sci Rep; 2021 Jan; 11(1):2593. PubMed ID: 33510368
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis.
Quintanilla HD; Liu Y; Fatheree NY; Atkins CL; Hashmi SS; Floros J; McCormack FX; Rhoads JM; Alcorn JL
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):613-20. PubMed ID: 25539191
[TBL] [Abstract][Full Text] [Related]
3. Impact of Surfactant Protein-A on Immunomodulatory Properties of Murine and Human Breast Milk.
Meyer CM; Khan AM; Alcorn JL
J Pediatr Gastroenterol Nutr; 2022 Jul; 75(1):97-103. PubMed ID: 35442233
[TBL] [Abstract][Full Text] [Related]
4. Targeting the PXR-TLR4 signaling pathway to reduce intestinal inflammation in an experimental model of necrotizing enterocolitis.
Huang K; Mukherjee S; DesMarais V; Albanese JM; Rafti E; Draghi Ii A; Maher LA; Khanna KM; Mani S; Matson AP
Pediatr Res; 2018 May; 83(5):1031-1040. PubMed ID: 29360809
[TBL] [Abstract][Full Text] [Related]
5. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis.
Jilling T; Simon D; Lu J; Meng FJ; Li D; Schy R; Thomson RB; Soliman A; Arditi M; Caplan MS
J Immunol; 2006 Sep; 177(5):3273-82. PubMed ID: 16920968
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Epithelial TLR4 Activation Leads to Lung Injury in Neonatal Necrotizing Enterocolitis.
Jia H; Sodhi CP; Yamaguchi Y; Lu P; Martin LY; Good M; Zhou Q; Sung J; Fulton WB; Nino DF; Prindle T; Ozolek JA; Hackam DJ
J Immunol; 2016 Aug; 197(3):859-71. PubMed ID: 27307558
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-κB signaling pathways.
Yu R; Jiang S; Tao Y; Li P; Yin J; Zhou Q
J Cell Physiol; 2019 Aug; 234(8):13431-13438. PubMed ID: 30618088
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I reduces the occurrence of necrotizing enterocolitis by reducing inflammatory response and protecting intestinal mucosal barrier in neonatal rats model.
Tian F; Liu GR; Li N; Yuan G
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4711-4719. PubMed ID: 29131241
[TBL] [Abstract][Full Text] [Related]
9. Surfactant protein-D attenuates the lipopolysaccharide-induced inflammation in human intestinal cells overexpressing toll-like receptor 4.
Saka R; Wakimoto T; Nishiumi F; Sasaki T; Nose S; Fukuzawa M; Oue T; Yanagihara I; Okuyama H
Pediatr Surg Int; 2016 Jan; 32(1):59-63. PubMed ID: 26510735
[TBL] [Abstract][Full Text] [Related]
10. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium.
Good M; Siggers RH; Sodhi CP; Afrazi A; Alkhudari F; Egan CE; Neal MD; Yazji I; Jia H; Lin J; Branca MF; Ma C; Prindle T; Grant Z; Shah S; Slagle D; Paredes J; Ozolek J; Gittes GK; Hackam DJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11330-5. PubMed ID: 22733781
[TBL] [Abstract][Full Text] [Related]
11. Human breast milk oligosaccharides attenuate necrotizing enterocolitis in rats by suppressing mast cell accumulation, DPPI activity and TLR4 expression in ileum tissue, and regulating mitochondrial damage of Caco-2 cells.
He-Yang J; Zhang W; Liu J; Xue P; Zhou X
Int Immunopharmacol; 2020 Nov; 88():106881. PubMed ID: 32795899
[TBL] [Abstract][Full Text] [Related]
12. Paneth-cell-disruption-induced necrotizing enterocolitis in mice requires live bacteria and occurs independently of TLR4 signaling.
White JR; Gong H; Pope B; Schlievert P; McElroy SJ
Dis Model Mech; 2017 Jun; 10(6):727-736. PubMed ID: 28450472
[TBL] [Abstract][Full Text] [Related]
13. Single-Immunoglobulin Interleukin-1-Related Receptor regulates vulnerability to TLR4-mediated necrotizing enterocolitis in a mouse model.
Fawley J; Cuna A; Menden HL; McElroy S; Umar S; Welak SR; Gourlay DM; Li X; Sampath V
Pediatr Res; 2018 Jan; 83(1-1):164-174. PubMed ID: 28846670
[TBL] [Abstract][Full Text] [Related]
14. Emodin protects against intestinal and lung injury induced by acute intestinal injury by modulating SP-A and TLR4/NF-κB pathway.
Qian J; Li G; Jin X; Ma C; Cai W; Jiang N; Zheng J
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32915230
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and Apoptosis: Dual Mediator Role for Toll-like Receptor 4 in the Development of Necrotizing Enterocolitis.
Zhou Y; Li Y; Zhou B; Chen K; Lyv Z; Huang D; Liu B; Xu Z; Xiang B; Jin S; Sun X; Li Y
Inflamm Bowel Dis; 2017 Jan; 23(1):44-56. PubMed ID: 27849634
[TBL] [Abstract][Full Text] [Related]
16. TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection.
Awasthi S; Singh B; Ramani V; Xie J; Kosanke S
PLoS One; 2019; 14(1):e0210979. PubMed ID: 30689633
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4-mediated enteric glia loss is critical for the development of necrotizing enterocolitis.
Kovler ML; Gonzalez Salazar AJ; Fulton WB; Lu P; Yamaguchi Y; Zhou Q; Sampah M; Ishiyama A; Prindle T; Wang S; Jia H; Wipf P; Sodhi CP; Hackam DJ
Sci Transl Med; 2021 Sep; 13(612):eabg3459. PubMed ID: 34550727
[TBL] [Abstract][Full Text] [Related]
18. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.
Awasthi S; Brown K; King C; Awasthi V; Bondugula R
J Pharmacol Exp Ther; 2011 Mar; 336(3):672-81. PubMed ID: 21159752
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D ameliorates neonatal necrotizing enterocolitis via suppressing TLR4 in a murine model.
Shi Y; Liu T; Zhao X; Yao L; Hou A; Fu J; Xue X
Pediatr Res; 2018 May; 83(5):1024-1030. PubMed ID: 29281615
[TBL] [Abstract][Full Text] [Related]
20. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.
Leaphart CL; Cavallo J; Gribar SC; Cetin S; Li J; Branca MF; Dubowski TD; Sodhi CP; Hackam DJ
J Immunol; 2007 Oct; 179(7):4808-20. PubMed ID: 17878380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
